New Zealand markets closed

ABBV Jul 2022 165.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 03:24PM EDT. Market open.
Full screen
Previous close0.0500
Open0.0200
Bid0.0000
Ask0.0000
Strike165.00
Expiry date2022-07-15
Day's range0.0200 - 0.0700
Contract rangeN/A
Volume15
Open interestN/A
  • Zacks

    AbbVie (ABBV) Gains But Lags Market: What You Should Know

    AbbVie (ABBV) closed the most recent trading day at $153.93, moving +0.08% from the previous trading session.

  • Motley Fool

    This Blockbuster Drug from AbbVie Is Closer to Another Major Indication

    The European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) recently adopted a positive opinion that recommended the approval of AbbVie's (NYSE: ABBV) Rinvoq for what would be its fifth indication in that market. This would be to treat patients with moderate-to-severe ulcerative colitis who had an inadequate response to conventional therapies or biologic agents. A decision for Rinvoq as a treatment for moderate-to-severe ulcerative colitis patients from the European Commission is expected in the third quarter of this year.

  • Motley Fool

    3 Stocks You Can Buy and Hold for Decades

    Three little words can make you a lot of money over the long term: Buy and hold. Here's why they picked AbbVie (NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (AbbVie): Pharma giant AbbVie is currently defying gravity.